Hormonal therapy of endometrial cancer

被引：40

作者：

Markman, M ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77025 USA

来源：

EUROPEAN JOURNAL OF CANCER | 2005年 / 41卷 / 05期

关键词：

endometrial cancer; hormonal therapy; progesterone;

D O I：

10.1016/j.ejca.2004.12.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Hormonal therapy of advanced or recurrent endometrial cancer is a well-established therapeutic option. Patients most likely to respond have lower grade tumours and possess progesterone receptors on the surface of their cancer cells. (c) 2004 Elsevier Ltd. All rights reserved.

引用

页码：673 / 675

页数：3

共 28 条

[1]

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer [J].

Bergman, L ;

Beelen, MLR ;

Gallee, MPW ;

Hollema, H ;

Benraadt, J ;

van Leeuwen, FE .

LANCET, 2000, 356 (9233) :881-887

[2]

TAMOXIFEN AND ENDOMETRIAL CARCINOMA - ALTERATIONS IN ESTROGEN AND PROGESTERONE RECEPTORS IN UNTREATED PATIENTS AND COMBINATION HORMONAL-THERAPY IN ADVANCED NEOPLASIA [J].

CARLSON, JA ;

ALLEGRA, JC ;

DAY, TG ;

WITTLIFF, JL .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (02) :149-153

[3]

A phase II study of leuprolide in advanced/recurrent endometrial cancer [J].

Covens, A ;

Thomas, G ;

Shaw, P ;

Ackerman, I ;

Osborne, R ;

Lukka, H ;

Carey, M ;

Franssen, E ;

Roche, K .

GYNECOLOGIC ONCOLOGY, 1997, 64 (01) :126-129

[4]

PROGNOSTIC-SIGNIFICANCE OF HORMONE RECEPTORS IN ENDOMETRIAL CANCER [J].

CREASMAN, WT .

CANCER, 1993, 71 (04) :1467-1467

[5]

Dai D, 2002, CANCER RES, V62, P881

[6]

FIORICA J, 2000, P AN M AM SOC CLIN, V19, pA379

[7]

ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14 [J].

FISHER, B ;

COSTANTINO, JP ;

REDMOND, CK ;

FISHER, ER ;

WICKERHAM, DL ;

CRONIN, WM ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

EVANS, J ;

FARRAR, W ;

KAVANAH, M ;

LICKLEY, HL ;

MARGOLESE, R ;

PATERSON, AHG ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) :527-537

[8]

PRESENCE OF GONADOTROPIN-RELEASING-HORMONE RECEPTOR AND ITS MESSENGER-RIBONUCLEIC-ACID IN ENDOMETRIAL CARCINOMA AND ENDOMETRIUM [J].

IMAI, A ;

OHNO, T ;

IIDA, K ;

FUSEYA, T ;

FURUI, T ;

TAMAYA, T .

GYNECOLOGIC ONCOLOGY, 1994, 55 (01) :144-148

[9]

Cancer statistics, 2004 [J].

Jemal, A ;

Tiwari, RC ;

Murray, T ;

Ghafoor, A ;

Samuels, A ;

Ward, E ;

Feuer, EJ ;

Thun, MJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) :8-29

[10]

Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer [J].

Jeyarajah, AR ;

Gallagher, CJ ;

Blake, PR ;

Oram, DH ;

Dowsett, M ;

Fisher, C ;

Oliver, RTD .

GYNECOLOGIC ONCOLOGY, 1996, 63 (01) :47-52

← 1 2 3 →